{
    "code": 0,
    "data": [
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Quarter Ended 31.12.2025",
            "news_body": "Result for the quarter ended 31.12.2025",
            "news_id": "10adf074-5a27-4131-98f9-1d5df4092719",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=313c042f-551a-4c90-9e2f-52c95234efeb.pdf",
            "news_date": "2026-02-09 13:39:04",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result Sept 2025",
            "news_body": "Result Sept 2025",
            "news_id": "14062eb4-bff1-4dcd-8f9b-59d589960245",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b8dc552-b44d-46a8-a0a4-4c3f57ba8b59.pdf",
            "news_date": "2025-11-04 13:36:45",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result",
            "news_body": "result",
            "news_id": "1a3e9958-3ca0-4728-abb8-cc8d2fad954d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b376f475-d9f2-40b3-b245-3eb0be430658.pdf",
            "news_date": "2025-08-07 14:28:27",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result For The Year Ended 31.03.2025",
            "news_body": "Result for the year ended 31.03.2025",
            "news_id": "dfe74a58-3ce8-4ad8-a679-90066fb710aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b201056e-dfaf-46b1-b988-47d6e267ae68.pdf",
            "news_date": "2025-05-20 14:13:50",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For The Quarter Ended 31.12.2024",
            "news_body": "Financial Result for the quarter ended 31.12.2024",
            "news_id": "14536e78-f6ab-4338-88f2-f98d16986d00",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e74a119-da6b-4611-a29d-c4166413b867.pdf",
            "news_date": "2025-02-04 14:05:43",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For The Quarter And Half Year Ended  30.09.2024",
            "news_body": "Financial Result for the quarter and half year ended 30.09.2024",
            "news_id": "69979e47-8459-44b8-8313-f1056f2cc12d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c50ab2-9d75-4106-b979-4d338fa769d4.pdf",
            "news_date": "2024-11-11 13:39:36",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30.06.2024",
            "news_body": "Financial Results for the quarter ended 30.06.2024",
            "news_id": "43b6305a-ac46-41da-b05f-74fcfaa0ffe9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604bc41c-a573-4e66-a858-f2ce04f2ed34.pdf",
            "news_date": "2024-08-07 13:37:40",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Year Ended 31.03.2024",
            "news_body": "Financial Results for the year ended 31.03.2024",
            "news_id": "f5e10bdd-8c69-491d-830f-b8655d9497b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8d54b69-9127-4847-904c-c3aa7dac8bda.pdf",
            "news_date": "2024-05-21 15:50:20",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company 3Rd Quarter And 9 Month Ended 31St December 2023.",
            "news_body": "Please find enclosed herewith Unaudited Financial Results for 3rd Quarter and 9 Months ended 31st December 2023.",
            "news_id": "06040aa9-e471-4d3e-8d61-c8eab2444a29",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b139566d-2418-4530-ae75-bb43297b3814.pdf",
            "news_date": "2024-02-12 13:38:06",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30Th September, 2023",
            "news_body": "Unaudited Financial Results for the 2nd quarter and half year ended 30th September, 2023",
            "news_id": "2264475d-56a5-4ffb-acfd-8ba9aa5cdc3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b8749e3-9415-4ee4-bdec-4f556c14122d.pdf",
            "news_date": "2023-11-08 14:38:31",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The 1St Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial Results of the Company for the 1st quarter ended June 30, 2023",
            "news_id": "1238ed05-487d-4bab-a73b-259fc1af682e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3785447-91b3-4807-b1df-fae5928dd67c.pdf",
            "news_date": "2023-08-09 16:17:19",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Under Regulation 30 & 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Further to our letter dated May 11, 2023 and in compliance with Regulation 30 read with Schedule III and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that the Board of Directors of the Company at its meeting held today have approved the following:<BR> 1. Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023 along with the Audit Report by the Statutory Auditors thereon - Enclosed.<BR> 2. Declaration in respect of Audit Report on the Financial Statement for the financial year ended March 31, 2023 with unmodified opinion from MD & CFO.<BR> <BR> The Meeting of the Board of Directors commenced at 12:30 pm and concluded at 3:45 p.m.<BR> <BR> The above is for your information and record.<BR>",
            "news_id": "5d24eebd-ceae-405a-9c5f-71486113b64e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a312cd57-79ef-4040-9cfc-fb110cffc170.pdf",
            "news_date": "2023-05-24 16:14:45",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Further to our letter dated May 11, 2023 and in compliance with Regulation 30 read with Schedule III and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that the Board of Directors of the Company at its meeting held today have approved the following:<BR> 1. Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023 along with the Audit Report by the Statutory Auditors thereon - Enclosed.<BR> 2. Declaration in respect of Audit Report on the Financial Statement for the financial year ended March 31, 2023 with unmodified opinion from MD & CFO.<BR> <BR> The Meeting of the Board of Directors commenced at 12:30 pm and concluded at 3:45 p.m.<BR> <BR> The above is for your information and record.  <BR>",
            "news_id": "839cd1c9-3c48-44a9-8da8-e6c4cabe27a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a647a7ea-1762-451b-8a75-381c4a4d45bd.pdf",
            "news_date": "2023-05-24 15:59:50",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For Quarter Ended 31.12.2022 With Digital Signature",
            "news_body": "Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report by the Statutory Auditors thereon.",
            "news_id": "628b3ba1-b87f-40a2-ad17-28fe9804e385",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edfeb6ff-fb71-44cf-b78a-f26728e1eea3.pdf",
            "news_date": "2023-02-03 18:37:46",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report by the Statutory Auditors thereon",
            "news_id": "3da428fc-39bc-4e29-91be-c1d006ed6ee6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=537be339-173d-47ee-9581-912ad871d14d.pdf",
            "news_date": "2023-02-03 15:47:00",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Further to our letter dated January 23, 2023 and in compliance with Regulation 30 read with Schedule III and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that the Board of Directors of the Company at its meeting held today have approved the agenda item as per the attached file.<BR> <BR> The Meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 03:20 p.m.",
            "news_id": "adecec3b-af4f-49ee-a9d1-10fc1563af46",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=557dd7bd-fe03-4a9a-936c-66eb3724d88a.pdf",
            "news_date": "2023-02-03 15:39:10",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "news_id": "a8df147a-8893-4789-b0fd-6b75aa5f1828",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d34a4be9-569a-42f2-80e8-3e6b3be7b606.pdf",
            "news_date": "2022-11-24 17:19:13",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q2fy23 Results",
            "news_body": "Q2Fy23 Results",
            "news_id": "c197a9d3-4f9c-47a6-8770-eb81f857039f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ba0ee3d-4e95-4d1d-b529-188f7419a59e.pdf",
            "news_date": "2022-11-10 16:14:50",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Q2FY23 Results",
            "news_body": "Q2FY23 Results",
            "news_id": "777396e7-1bbb-4773-9ca8-e0413e9e7cf0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d77c4928-c8a2-4179-b63f-1e5b037b8359.pdf",
            "news_date": "2022-11-10 16:07:56",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter Ended 30Th June, 2022",
            "news_body": "we herewith submit to the Exchange the quick results for the quarter ended 30th June, 2022 along with the Auditor- Limited review Report thereon  as approved by the Board of Directors at their meeting held on 1st August, 2022.<BR> .<BR>",
            "news_id": "73c4be49-6e88-4bfc-a84c-3c771507f085",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfaf13c3-9495-47b3-9d0f-ab64f6a758bf.pdf",
            "news_date": "2022-08-01 16:28:26",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Intimation To Stock Exchanges Under Regulation 30 Regards Outcome Of Board Meeting",
            "news_body": "We wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 1st August, 2022:<BR> <BR> (a) The un-audited financial results for the quarter ended 30th June, 2022 along with the Auditor's Limited Review Report thereon (Enclosed herewith) have been adopted by the Board.<BR> (b) The Board has taken note of the Resignation email of Ms.Taruni Banda, Company Secretary and Compliance officer dated June 27th, 2022, has accepted/approved the Resignation and relieved her from all responsibilities w.e.f 6th August, 2022.<BR> (c) The Board report and annexures have been approved for the 30th Annual General meeting. <BR>",
            "news_id": "7782d72e-9208-404d-8810-436f0a3075ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c179710e-480e-42b7-a111-62fe84fda9d8.pdf",
            "news_date": "2022-08-01 16:15:02",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "We herewith submit to you the disclosure of related party transactions for the half year ended 31st March 2022 as required under Reg. 23(9) of SEBI (LODR) Regulations, 2015.",
            "news_id": "96ff9d06-f866-486a-a0c4-ab16a4cb7c80",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b6575e3-bc2a-41fe-a9d7-78781ad66566.pdf",
            "news_date": "2022-05-27 11:23:05",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Quick Result. <BR> <BR>",
            "news_body": "We herewith submit to the Exchange the quick results for the quarter and year ended 31st March, 2022 along with the Auditor Report thereon (Enclosed herewith) as approved by the Board of Directors at their meeting held on 23rd May, 2022.",
            "news_id": "d6b75fe5-c01b-4d7f-ac42-e7bdb125a0d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e4f51d9-9de4-46c7-92a3-fb38db5b131f.pdf",
            "news_date": "2022-05-23 15:14:43",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "We wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 23rd May, 2022:<BR> <BR> (a) The audited financial results for the quarter and Year ended 31st March, 2022 along with the Auditor's Report thereon have been adopted by the Board.<BR> <BR>",
            "news_id": "04872861-551d-4ec3-9615-14198b119ea6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8abb307c-3559-48ce-b37c-cbf2e6e9851f.pdf",
            "news_date": "2022-05-23 15:04:58",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended 31St December, 2021",
            "news_body": "Unaudited financial results as approved by the Board of Directors for the quarter and three months ended 31st December, 2021 along with limited review report given by the Statutory Auditors",
            "news_id": "d82162b8-cbf4-4219-8b8c-81bf6146d739",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9fcaf68-d309-43c9-8a8c-36848c2c2571.pdf",
            "news_date": "2022-02-12 16:11:18",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2021",
            "news_body": "The Board of Directors in their meeting held on 12th February, 2022 have inter alia considered and approved the unaudited financial results for the quarter and nine months ended 31st December, 2021 and taken on record the limited review report issued by the Statutory Auditors of the Company",
            "news_id": "0971d219-65fd-4bc0-840b-172789e37f75",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec1fc2e9-8a4f-44ce-984f-740ac6a14575.pdf",
            "news_date": "2022-02-12 15:40:00",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Quarter And Half Year Ended 30Th September, 2021",
            "news_body": "We herewith submit to you the disclosure of related party transactions for the half year ended 30th September 2021 as required under Reg. 23(9) of SEBI (LODR) Regulations, 2015.",
            "news_id": "02988b92-3290-4750-b3fb-97caeaa44938",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=271c5159-20b2-4a90-99c5-5fec0f92b7f7.pdf",
            "news_date": "2021-11-09 14:47:47",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 9Th November, 2021",
            "news_body": "we wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 9th November, 2021:<BR> <BR> 1. The unaudited financial results for the quarter and half year ended 30th September 2021 along with the Limited Review Report thereon  have been adopted by the Board.<BR> <BR> 2. Appointment of Mr. Jitendra Shah (DIN: 09377846) as Additional Director, Non-Executive Category.<BR> <BR> 3.  The Board has taken note of Resignation of Mr. E J Babu (DIN: 06759124) as Director with effect from 10th November, 2021.<BR> <BR>",
            "news_id": "face8bf1-fba4-4743-b93e-3508fa36a5b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02ef3785-0f70-4293-8e0a-b5e5c0fafacb.pdf",
            "news_date": "2021-11-09 14:15:44",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quick Results For The Quarter And Half Year Ended 30Th September, 2021",
            "news_body": "Quick results for the quarter and half year ended 30th September, 2021 along with the Limited Review Report thereon (Enclosed herewith) as approved by the Board of Directors at their meeting held on 9th November, 2021.",
            "news_id": "a59958fd-c275-4dbe-afe0-14a3b41157b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5ce1b28-44dc-4cf1-9b02-52d57dde5d7c.pdf",
            "news_date": "2021-11-09 14:09:28",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Quick Result For Quarter 30Th June, 2021",
            "news_body": "We refer to the above mentioned subject, we herewith submit to the Exchange the quick results for the quarter ended 30th June, 2021 as approved by the Board of Directors at their meeting held on 30th July, 2021.",
            "news_id": "148ae819-cda7-46bc-8c82-acd53f6bf01f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=413f50a2-034f-4770-ad62-24d673c82d76.pdf",
            "news_date": "2021-07-30 15:33:06",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Out Come Of Board Meeting",
            "news_body": "we wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 30th July, 2021:<BR> <BR> (a) The Un-Audited financial results for the quarter ended 30th June, 2021 along with the Limited Review Report thereon (Enclosed herewith) have been adopted by the Board.<BR> (b) The Board has taken note of Resignation of Mr. Manish Jain, Director from the Board.<BR> (c) The Board has taken note of end of tenure of Mr. Avinash Ravi as Managing Director and accordingly Change in designation of Mr. Avinash Ravi from Managing Director to Non-Executive Director.<BR> (d) Appointment of Mr. Pabitra Bhattacharya as Additional Director and Managing Director of the Company subject to approval of members at the ensuing Annual General Meeting, whose Brief profile is attached herewith.<BR>",
            "news_id": "e4443001-3a11-4dca-a35e-63117856c6e8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc4324a6-318b-4cea-9682-404e2aa01129.pdf",
            "news_date": "2021-07-30 15:29:37",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Disclosure For Quarter And Year Ended 31St March, 2021",
            "news_body": "We herewith submit to you the disclosure of related party transactions for the half year ended 31st March 2021 as required under Reg. 23(9) of SEBi (LODR) Regulations, 2015",
            "news_id": "772418ea-0f33-4978-91ec-196c5ddf13a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=300acad5-ee31-49ac-8587-b7f81205dad5.pdf",
            "news_date": "2021-06-01 21:40:43",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Quick Result For FY 31St March, 2021",
            "news_body": "we herewith submit to the Exchange the quick result for the quarter and year ended 31st March, 2021 as approved by the Board of Directors at their meeting held on 27th May, 2021.<BR>  <BR>  <BR> <BR>",
            "news_id": "49308d32-18ec-4581-b5bd-8b01e5f17597",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0b23612-9e22-4b12-bf42-bf95f92d0fe0.pdf",
            "news_date": "2021-05-27 14:14:37",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KREBSBIO",
            "disp": "Krebs Biochemicals & Industries",
            "bse_code": 524518,
            "isin": "INE268B01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Dated 27-05-2021",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ['SEBI LODR Regulations'], we wish to inform the following outcome of the meeting of the Board of Directors held today, i.e. 27th May, 2021:<BR> <BR> (a) The Audited financial results for the quarter and Year ended 31st March, 2021 along with the Auditor Report thereon (Enclosed herewith) have been adopted by the Board.<BR>",
            "news_id": "d575d625-3d96-4b8f-b19d-0588b55f989a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9004eb7-f775-459e-ad85-0e46f8ffa00e.pdf",
            "news_date": "2021-05-27 14:11:25",
            "seo": "krebs-biochemicals-industries-ltd",
            "ltp": 57.28,
            "ch": 0.28000000000000114,
            "pch": 0.4912280701754406,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 1937,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}